TRIM33 and cancer: A reliable anti-TIF1-gamma autoantibody ELISA would greatly facilitate the detection of anti-TIF1-gamma autoantibodies and at the same time potentially be used to predict cancer risk by providing anti-TIF1-gamma autoantibody levels.